EEMAGINE MEDICAL IMAGING SOLUTIONSGMBH

Their core work

eemagine is a Berlin-based SME that develops and manufactures professional EEG (electroencephalography) systems and brain imaging hardware for research and clinical environments. Their core product line provides high-density, mobile EEG amplifiers used in both laboratory and real-world settings. In EU research projects, they serve as the technology partner — supplying instrumentation, integrating physiological monitoring systems, and enabling experiments that would not be possible without specialized hardware. Their participation in neonatal neuroscience and multi-brain scanning projects shows that their equipment is trusted for sensitive, high-stakes research at the frontier of neurophysiology.

What they specialise in

How they've shifted over time

eemagine's early H2020 work centered on neonatal neuroscience — applying EEG and near-infrared spectroscopy to clinical safety assessment of newborns, a well-defined medical application with direct patient benefit. Their more recent participation shifts toward social and cognitive neuroscience: EMBRACE targets "hyperbrain scanning" and interpersonal coordination, meaning simultaneous recording from multiple participants at once. This progression suggests the company's hardware is becoming capable enough — in terms of mobility, simultaneous channels, and signal quality — to support the technically demanding hyperscanning paradigm that is rapidly growing in basic research.

eemagine is moving from clinical neonatal applications toward multi-participant neuroscience research, suggesting future collaboration interest in social cognition, human-robot interaction, and real-world brain monitoring studies.

How they like to work

eemagine joins consortia exclusively as a participant and has never led an H2020 project — consistent with their role as a technology supplier embedded in academically led research teams. With 12 partners across 7 countries in just two projects, their consortia are moderately sized and internationally diverse. They appear to function as a specialist hardware contributor: the group that provides and integrates the instrumentation while academic partners drive the scientific questions.

eemagine has built connections with 12 unique partner organizations across 7 countries through two MSCA-funded projects. Their network is spread across Europe, consistent with MSCA's pan-European mobility mandate, though the specific partner countries are not listed in the source data.

What sets them apart

eemagine occupies a rare niche: a commercial EEG hardware manufacturer that actively participates in EU-funded neuroscience research rather than simply selling equipment. This means they both shape and are shaped by frontier research needs, giving them an unusually close feedback loop between product development and scientific application. For consortium builders, they bring real hardware — not just expertise — which is often a practical bottleneck in neuroimaging projects.

Highlights from their portfolio

• INFANS
  The largest single funding award for eemagine (€505,577), targeting neonatal brain safety assessment by combining EEG with near-infrared spectroscopy — a clinically significant and technically complex multimodal challenge.
• EMBRACE
  Positions eemagine at the frontier of hyperscanning research — simultaneous multi-person EEG recording for studying interpersonal coordination — a rapidly growing and technically demanding field with few commercial hardware providers.